Bailey R Fritz

Bailey R Fritz

Auto-generated profile, based on publicly available information

Bailey R Fritz

Department of Anatomy & Physiology, College of Veterinary Medicine, Kansas State University , Manhattan, KS, 66506

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Journal of Dairy Science
Verified
Journal Article
Open access
BFB.R. Fritz
B.R. Fritz
MKMichael Kleinhenz
Michael Kleinhenz
SMS.R. Montgomery
S.R. Montgomery
GMG. Magnin
G. Magnin
MMMiriam Martin
Miriam Martin
Johann CoetzeeJohann Coetzee
Johann Coetzee
The objectives of this descriptive study were to (1) describe the pharmacokinetics of salicylic acid (SA) in the milk and plasma of postpartum dairy cattle following oral administration of acetylsalicylic acid (ASA; aspirin), (2) to estimate a recommended milk withdrawal period for dairy cattle treated with ASA, and (3) to determine the effect of ASA administration on plasma prostaglandin E2 metabolite (PGEM) concentrations. Primiparous (n = 3) and multiparous (n = 7) postpartum Holstein dairy cows received 2 oral treatments with ASA at 200 mg/kg of body weight, 24 h apart. Concentrations of SA in plasma and milk from 0 h through 120 h after ASA administration were analyzed using ultra performance liquid chromatography triple quadrupole mass spectrometry and a milk withdrawal period was estimated using the United States Food and Drug Administration Milk Discard App in R. Two withdrawal periods were estimated: (1) a whole-herd treatment scenario with no dilution factor and (2) an individual animal treatment scenario with a bulk tank factor included in analysis. Plasma PGEM concentrations in samples from 0 h to 24 h after ASA administration were determined using a commercially available competitive ELISA. Milk SA concentrations were undetected in all cows by 48 h after the last ASA treatment. Secondary peaks were observed in plasma at 58 and 82 h after the last treatment and in milk at 87 h after the last treatment. In the absence of a tolerance for SA in milk, the estimated milk withdrawal periods were (1) 156 h for the whole-herd treatment scenario and (2) 120 h for the individual animal treatment scenario. Plasma PGEM concentrations were reduced compared with baseline for up to 12 h after ASA administration, with the greatest reduction observed at 2 h. Results from this study suggest that the current milk withhold recommendation for dairy cattle administered ASA may need revision to 120 h (5 d) and that ASA administration may mitigate postpartum inflammation through reduction in prostaglandin production for up to 12 h after treatment. Pharmacokinetic and milk withdrawal data from this study will inform future recommendations for extra-label use of aspirin in postpartum dairy cows. Further research is required to determine the basis for the secondary SA peaks and to elucidate the long-term effects of ASA administration on dairy cow health.

7 January 2025 in Translational Animal Science
Verified
Journal Article
Open access
BFBailey R Fritz
Bailey R Fritz
MKMichael Kleinhenz
Michael Kleinhenz
JGJason J Griffin
Jason J Griffin
MWMikaela Weeder
Mikaela Weeder
GMGeraldine Magnin
Geraldine Magnin
Johann CoetzeeJohann Coetzee
Johann Coetzee
Recent legislative approval of industrial hemp (IH) cultivation has increased interest in the possibility of using IH and IH byproducts in livestock feed. Understanding the therapeutic effects of IH is critical for regulatory decisions and application to the cattle industry. The objective of this pilot study was to describe the effects of IH administration on stress and inflammatory biomarkers and activity in cattle experiencing repeated transportation. Twelve Holstein steers (430 kg, SEM = 3.4; 947 lb, SEM = 7.6) were assigned randomly to treatment sequences (n = 3 per sequence) in a 4 × 4 Latin Square design study (four periods and four treatment sequences). Treatments consisted of one of two drugs (IH or placebo; HEMP, PLBO) and one of two transportation events (transport or control; TRANS, CNTL) during each period so that every steer received all treatment combinations during the study. Industrial hemp was dosed at 5.5 mg/kg cannabidiolic acid (CBDA), with IH or placebo given once by oral bolus immediately prior to the transport or control event. Body weight, accelerometry, kinetic gait analysis, mechanical nociceptive threshold, infrared thermography, complete blood count (CBC), serum biochemistry, blood cortisol, prostaglandin E2 metabolite (PGEM), and serum amyloid A (SAA) were assessed using multiple linear regression. Summary statistics for plasma cannabinoid concentration were generated. There was a drug by transport by time interaction for change in PGEM from baseline (P = 0.03): steers in the HEMP-CNTL group had negative change at 48 h, whereas PLBO-CNTL steers had positive change at 48 h. Both TRANS and CNTL steers had increased lying times in the period immediately after transport. Steers in the TRANS group had greater body weight loss (P <0.0001), neutrophils (P < 0.0001), monocytes (P = 0.04), blood glucose (P < 0.0001), and total protein (P <0.0001) compared to CNTL steers immediately following transport. Cortisol area under the curve values were greater for TRANS versus CNTL steers (P < 0.0001). Lymphocyte concentrations were decreased for TRANS steers compared to CNTL following transport (P < 0.0001). There was a transport by time interaction for SAA (P < 0.0001), with TRANS steers at 24 and 32 h having the greatest SAA concentrations. Further investigation is required to confirm if feeding IH reduces PGEM. Novel outcomes evaluated in this pilot study will assist in design of future transportation trials.

4 January 2025 in Journal of Animal Science
Verified
Journal Article
Open access
BFBailey R Fritz
Bailey R Fritz
MKMichael D Kleinhenz
Michael D Kleinhenz
JGJason J Griffin
Jason J Griffin
MWMikaela Weeder
Mikaela Weeder
ANAlyssa A Nelson
Alyssa A Nelson
JCJohann F Coetzee
Johann F Coetzee
With recent legalization of industrial hemp (IH) production and increased interest in including IH and its byproducts in cattle feed, there is a need to establish the pharmacokinetic profiles of cannabinoids in cattle and guidelines for animal surveillance programs to ensure safety of cattle products entering the food supply. Our group has previously described the pharmacokinetics of cannabidiolic acid (CBDA) and concentrations of other cannabinoids in plasma. In the present study, the plasma cannabinoid concentrations in twelve (12) Holstein steers receiving alfalfa pellet placebo (PLBO), chlortetracycline (CTC) pellets (1.1 mg/kg/d), IH (5.5 mg/kg/d CBDA; HEMP), or a combination of CTC and IH (COMBO) once daily for 63 d were evaluated. Plasma samples were collected every 7 d from day −7 to 77. Eleven cannabinoids were detected above the lower limit of quantification (LLOQ), with the cannabinoid (−)-7-nor-7-carboxy cannabidiol (CBD-7-acid) reaching the highest concentrations. All cannabinoids except CBD-7-acid were below LLOQ by 14 d after final hemp administration. In cattle not receiving IH, CBD-7-acid was detected in multiple steers and timepoints. CBDA was detected in 4 samples (2 steers from each of the PLBO and CTC groups). Both 9-THC and its precursor, THCA, were detected above LLOQ in a singular sample from a steer in the CTC group. These findings suggest that cattle not receiving IH could have detectable concentrations of CBD-7-acid in the blood if cohoused with animals that are exposed to IH. Sample contamination may have been responsible for the detectable 9-THC, THCA, and CBDA concentrations. Based on our results, CBD-7-acid may be a useful tool for screening cattle for IH exposure. However, given the consistent, detectable concentrations in groups not administered IH, a confirmatory test or specific criteria for interpreting CBD-7-acid concentrations would be warranted. These data will help inform decisions regarding surveillance and tolerances for cannabinoid testing in food animals and animal products entering the food supply.